Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Fd&c Yellow No. 5, also known as Tartrazine, is a synthetic azo dye used as a coloring agent and classified as a Standardized Chemical Allergen [EPC]. It is clinically significant due to its potential to cause hypersensitivity reactions, particularly in individuals with aspirin sensitivity.
Name
Fd&c Yellow No. 5
Raw Name
FD&C YELLOW NO. 5
Category
Standardized Chemical Allergen [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Fd&c Yellow No. 5
Fd&c Yellow No. 5, also known as Tartrazine, is a synthetic azo dye used as a coloring agent and classified as a Standardized Chemical Allergen [EPC]. It is clinically significant due to its potential to cause hypersensitivity reactions, particularly in individuals with aspirin sensitivity.
Detailed information about Fd&c Yellow No. 5
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Fd&c Yellow No. 5.
Fd&c Yellow No. 5, chemically known as Tartrazine, is a synthetic lemon-yellow azo dye primarily derived from coal tar. Within the pharmacological landscape, it is classified by the FDA as a Standardized Chemical Allergen [EPC]. While it is most commonly recognized as a color additive in foods, drugs, and cosmetics, its clinical relevance stems from its role as a provocative agent in diagnostic allergy testing and its status as a significant excipient (inactive ingredient) that can trigger adverse physiological responses in sensitive populations. Fd&c Yellow No. 5 belongs to a class of compounds known as azo dyes, characterized by the presence of a nitrogen-to-nitrogen double bond (azo group), which is central to its chemical stability and its interaction with the human immune system.
The FDA first approved Fd&c Yellow No. 5 for use in the mid-20th century, but due to mounting evidence regarding hypersensitivity reactions, the agency implemented strict labeling requirements under 21 CFR 74.705. This regulation mandates that any drug product intended for human use that contains Fd&c Yellow No. 5 must specifically declare its presence in the 'Precautions' or 'Description' section of the labeling. This is a unique distinction shared by very few excipients, highlighting its clinical importance. In a clinical setting, healthcare providers view Fd&c Yellow No. 5 not as a therapeutic agent, but as a potential trigger for 'pseudo-allergic' reactions, which mimic IgE-mediated allergies but often follow different biochemical pathways.
As a Standardized Chemical Allergen, Fd&c Yellow No. 5 does not possess a traditional therapeutic mechanism of action (MOA) like an antibiotic or an antihypertensive. Instead, its 'action' is defined by its ability to interact with the immune system and inflammatory mediators. At the molecular level, Fd&c Yellow No. 5 is thought to act as a hapten (a small molecule that can elicit an immune response only when attached to a large carrier such as a protein).
The primary clinical mechanism involves the degranulation of mast cells and the subsequent release of histamine, leukotrienes, and prostaglandins. Unlike classic allergies, tartrazine-induced reactions are often non-immunologic (anaphylactoid). Research suggests that Fd&c Yellow No. 5 may inhibit the cyclooxygenase (COX-1) enzyme, similar to the action of nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin. This inhibition shifts the arachidonic acid metabolism toward the lipoxygenase pathway, leading to an overproduction of pro-inflammatory leukotrienes. This mechanism explains why individuals with 'aspirin-induced asthma' or the 'aspirin triad' (asthma, nasal polyps, and aspirin sensitivity) are at a significantly higher risk of reacting to Fd&c Yellow No. 5.
The pharmacokinetics of Fd&c Yellow No. 5 are unique because the molecule is largely poorly absorbed in its intact form. Instead, its metabolic fate is determined by the microflora of the gastrointestinal tract.
Fd&c Yellow No. 5 is utilized in two primary capacities within the medical and consumer sectors:
Fd&c Yellow No. 5 is not prescribed as a standalone medication but is found in the following forms:
> Important: Only your healthcare provider can determine if Fd&c Yellow No. 5 exposure (via medication or diagnostic testing) is appropriate for your specific medical history, especially if you have a known sensitivity to aspirin.
There is no 'therapeutic' dose for Fd&c Yellow No. 5, as it is not used to treat diseases. However, in the context of diagnostic testing (Oral Provocation Challenge), healthcare providers follow standardized protocols:
For general consumption, the Acceptable Daily Intake (ADI) established by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) is 0–7.5 mg per kg of body weight.
Pediatric exposure is common through flavored medications and pediatric suspensions. However, diagnostic testing in children is approached with extreme caution.
Because the metabolites of Fd&c Yellow No. 5 (sulfanilic acid) are primarily cleared by the kidneys, individuals with severe renal impairment (Stage 4 or 5 Chronic Kidney Disease) may experience delayed clearance of these metabolites. While no specific dose adjustments exist for the excipient, healthcare providers may prefer dye-free medication alternatives for these patients to avoid unnecessary metabolic load.
Since the primary metabolism occurs via gut bacteria and not the cytochrome P450 system in the liver, hepatic impairment does not significantly alter the pharmacokinetics of Fd&c Yellow No. 5. However, patients with hepatic-related pruritus (itching) may find that azo dyes exacerbate their symptoms.
Elderly patients are more likely to have multiple comorbidities, such as asthma or cardiovascular disease requiring aspirin therapy. Because of the high prevalence of aspirin use in this population, healthcare providers should be particularly vigilant for tartrazine sensitivity in older adults.
When Fd&c Yellow No. 5 is present in a medication prescribed by your doctor:
If you are avoiding Fd&c Yellow No. 5 due to an allergy and accidentally ingest a product containing it, monitor yourself closely for symptoms. If you miss a dose of a medication that happens to contain this dye, follow the 'missed dose' instructions for the active ingredient provided by your pharmacist.
An 'overdose' of Fd&c Yellow No. 5 usually refers to an accidental high ingestion that triggers a severe hypersensitivity reaction.
> Important: Follow your healthcare provider's dosing instructions for any medication containing this additive. Do not adjust your dose or switch to a dye-free version without medical guidance.
In the general population, Fd&c Yellow No. 5 is well-tolerated. However, in sensitive individuals, common reactions include:
> Warning: Stop taking any medication containing Fd&c Yellow No. 5 and call your doctor immediately if you experience any of these serious reactions.
There is no significant evidence that long-term, low-level exposure to Fd&c Yellow No. 5 causes chronic organ toxicity or cancer in humans. Its primary long-term risk is the recurrence of acute hypersensitivity reactions in undiagnosed sensitive individuals, which can lead to chronic idiopathic urticaria (long-term hives) if the trigger is not identified and removed from the diet or medication regimen.
There are currently no FDA Black Box Warnings for Fd&c Yellow No. 5. However, the FDA does mandate a specific 'Precautions' statement for all human drugs containing the dye, warning of the risk of bronchial asthma in certain susceptible individuals.
Report any unusual symptoms or suspected reactions to your healthcare provider and the FDA's MedWatch program.
Fd&c Yellow No. 5 is one of the most widely scrutinized food and drug additives. The most critical safety information pertains to its role as a trigger for 'pseudo-allergic' reactions. Patients should be aware that even if they have tolerated the dye in the past, sensitivity can develop at any time. Furthermore, the presence of Fd&c Yellow No. 5 in a medication is often not obvious from the brand name alone; patients must proactively read labels or consult pharmacists.
No FDA black box warnings for Fd&c Yellow No. 5. However, its presence is a mandatory disclosure on all FDA-approved pharmaceutical labels due to its known allergenic potential.
There are no standard laboratory tests (like blood counts or liver panels) required specifically for Fd&c Yellow No. 5 exposure. However, for patients undergoing diagnostic provocation testing, continuous monitoring of the following is required:
Fd&c Yellow No. 5 does not cause sedation or cognitive impairment. However, if an individual experiences a hypersensitivity reaction (such as severe itching or respiratory distress), their ability to drive or operate machinery safely will be significantly compromised.
There is no direct chemical interaction between alcohol and Fd&c Yellow No. 5. However, alcohol can act as a vasodilator and may increase the speed of absorption of other substances in the gut, potentially worsening the severity of a skin reaction (hives) in sensitive individuals.
If a patient is found to be sensitive to Fd&c Yellow No. 5, the 'discontinuation' process involves identifying all sources of the dye in their current regimen. This is not a 'withdrawal' process but an avoidance strategy. Patients should work with their healthcare provider to find 'dye-free' (often white or uncolored) versions of their essential medications.
> Important: Discuss all your medical conditions, especially respiratory issues and drug allergies, with your healthcare provider before starting any medication containing Fd&c Yellow No. 5.
There are no drugs that are strictly 'contraindicated' for use with Fd&c Yellow No. 5 in the sense of a toxic chemical reaction. However, for an individual with a known and documented severe tartrazine allergy, any medication containing this excipient is contraindicated for that specific patient.
Fd&c Yellow No. 5 is a highly pigmented molecule. In very high doses (well beyond normal consumption), it could theoretically interfere with colorimetric laboratory tests, such as certain types of urinalysis that rely on visual color changes. However, at standard excipient levels, this is not a reported clinical concern.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you have a history of asthma or aspirin sensitivity.
Fd&c Yellow No. 5 must NEVER be used in individuals with:
Conditions requiring careful risk-benefit analysis include:
Patients should be aware of cross-sensitivity with:
> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing a medication that contains Fd&c Yellow No. 5.
Fd&c Yellow No. 5 is generally classified as 'Generally Recognized as Safe' (GRAS) by the FDA for use in foods and drugs. There is no evidence from human studies that it is a teratogen (causes birth defects). However, because pregnancy can alter the immune system and increase the risk of gestational asthma, pregnant individuals with a history of sensitivities should be cautious. It is always prudent to use dye-free medications during pregnancy when an equivalent option is available.
It is unknown whether the intact Fd&c Yellow No. 5 molecule or its metabolites (sulfanilic acid) are excreted in human breast milk. However, given the poor systemic absorption of the parent compound, the amount reaching the infant is likely negligible. There have been no reported adverse effects in nursing infants whose mothers consumed products containing the dye.
Fd&c Yellow No. 5 is ubiquitous in pediatric medications (e.g., yellow-colored ibuprofen suspensions or vitamin drops). While safe for the vast majority of children, a subset of the pediatric population may be sensitive. The 'Southampton Study' (2007) suggested a link between certain food colorings, including tartrazine, and increased hyperactivity in children. While the FDA did not find the evidence sufficient to ban the dye, parents of children with behavioral issues should discuss dye-free alternatives with their pediatrician.
In older adults, the primary concern is the higher likelihood of underlying cardiovascular disease and the concomitant use of aspirin or beta-blockers. As noted, these medications can either trigger a cross-reaction or complicate the treatment of an allergic response. Renal function should also be considered, as reduced GFR in the elderly can lead to slower elimination of the dye's metabolites.
No specific dosage adjustments are required for patients with kidney disease, but the primary metabolite, sulfanilic acid, is renally excreted. In patients with end-stage renal disease (ESRD), the accumulation of these metabolites is possible, though the clinical significance of this accumulation is currently unknown.
There are no specific precautions for hepatic impairment, as the liver is not the primary site of Fd&c Yellow No. 5 metabolism. However, patients with jaundice or cholestasis who already experience significant pruritus (itching) should be monitored, as azo dyes can sometimes worsen skin-related symptoms.
> Important: Special populations, particularly children and those with complex medication regimens, require individualized medical assessment regarding the use of products containing Fd&c Yellow No. 5.
Fd&c Yellow No. 5 (Tartrazine) acts as a Standardized Chemical Allergen. Its molecular mechanism does not involve binding to traditional therapeutic receptors. Instead, it is believed to act via:
| Parameter | Value |
|---|---|
| Bioavailability | <10% (as parent compound) |
| Protein Binding | Negligible |
| Half-life | 18–24 hours (for metabolites) |
| Tmax | 4–6 hours (for metabolites in urine) |
| Metabolism | Gut microflora (azo reduction) |
| Excretion | Renal (>90% of absorbed metabolites) |
Fd&c Yellow No. 5 is categorized as a Standardized Chemical Allergen [EPC]. It is part of the broader group of synthetic azo dyes. Related substances include Fd&c Yellow No. 6 and Fd&c Red No. 40, which are also frequently monitored for allergenic potential.
Common questions about Fd&c Yellow No. 5
Fd&c Yellow No. 5, also known as Tartrazine, is primarily used as a synthetic coloring agent in a wide variety of foods, drugs, and cosmetics to provide a lemon-yellow hue. In the medical field, it is also classified as a Standardized Chemical Allergen, meaning it can be used by specialists in diagnostic tests to identify specific patient sensitivities. It is found in many common medications, including some brands of vitamins, cough syrups, and prescription tablets. While it serves no therapeutic purpose, it helps in the identification and branding of medication. Patients with known sensitivities must check labels carefully, as the FDA requires its presence to be disclosed.
The most common side effects associated with Fd&c Yellow No. 5 are hypersensitivity reactions, particularly skin-related issues like urticaria (hives) and itching. In individuals who are sensitive to the dye, these symptoms can appear shortly after ingestion or contact. Some people may also experience mild respiratory symptoms, such as a runny or congested nose. While most people consume the dye without any issues, those with a history of asthma or aspirin allergy are significantly more likely to experience these side effects. If you notice a recurring rash or wheezing after taking certain medications, Fd&c Yellow No. 5 may be the cause.
There is no known direct chemical interaction between alcohol and Fd&c Yellow No. 5 that would cause a toxic reaction. However, alcohol can cause blood vessels to dilate and may increase the permeability of the gut lining, which could potentially speed up the absorption of the dye's metabolites. For individuals who are already sensitive to Fd&c Yellow No. 5, drinking alcohol might make a skin reaction, such as hives, appear more quickly or seem more severe. It is generally best to avoid alcohol if you are experiencing an active allergic reaction. Always consult your doctor regarding alcohol use with your specific primary medications.
Fd&c Yellow No. 5 is considered generally safe for use during pregnancy as it has not been linked to birth defects or developmental issues in human studies. Because it is poorly absorbed into the bloodstream, very little of the compound reaches the developing fetus. However, pregnancy can sometimes make the body more sensitive to allergens or exacerbate existing asthma. If you have a known sensitivity to azo dyes or aspirin, you should avoid products containing Fd&c Yellow No. 5 while pregnant. Many prenatal vitamins are available in 'dye-free' versions to minimize any unnecessary risks. Always discuss the ingredients of your supplements and medications with your obstetrician.
Since Fd&c Yellow No. 5 is not a therapeutic drug, it does not 'work' to treat a condition; however, if you are sensitive to it, a reaction typically occurs within 20 to 90 minutes after ingestion. This timeframe corresponds to the time it takes for the substance to reach the digestive tract and begin interacting with immune cells. In some cases, delayed reactions can occur several hours later as the dye is metabolized by gut bacteria. If used in a diagnostic patch test, the reaction might take 24 to 48 hours to become visible on the skin. The duration of a reaction can vary, with hives sometimes lasting for a full day or longer.
Yes, you can stop exposure to Fd&c Yellow No. 5 suddenly without any risk of withdrawal or physical dependence, as it is an inactive excipient and not a habit-forming drug. In fact, if you suspect you are allergic to it, stopping exposure is the recommended course of action. However, you should never stop taking a prescribed medication just because it contains the dye without first consulting your doctor. Your healthcare provider can help you find an alternative brand or a 'dye-free' version of the same medication so that your underlying condition remains treated. Abruptly stopping essential medications like heart or blood pressure pills can be dangerous.
Because Fd&c Yellow No. 5 is an inactive ingredient (a color additive), missing a 'dose' of the dye itself is not a medical concern. The focus should always be on the active medication that contains the dye. If you miss a dose of your medication, follow the specific instructions provided for that drug, which usually involve taking it as soon as you remember unless it is almost time for your next dose. Do not take extra medication to 'make up' for the dye. If you are using a dye-free alternative and accidentally take the version with Fd&c Yellow No. 5, simply monitor yourself for any signs of an allergic reaction.
There is no scientific evidence to suggest that Fd&c Yellow No. 5 causes weight gain. It is a non-nutritive additive used in very small quantities, meaning it contains no calories and does not affect the body's metabolic rate or fat storage. While it is often found in highly processed foods and sugary beverages that can contribute to weight gain, the dye itself is not the cause. Some people may experience temporary bloating or swelling if they have a mild allergic reaction to the dye, but this is not the same as gaining body fat. If you are concerned about weight changes, look at the overall nutritional profile of the foods you consume.
Fd&c Yellow No. 5 is present in thousands of different medications and is generally compatible with most drugs. However, a significant clinical interaction exists for people who take aspirin or other NSAIDs. Those who are sensitive to aspirin have a much higher risk of reacting poorly to Fd&c Yellow No. 5. Additionally, taking beta-blockers can make an allergic reaction to the dye more severe and harder to treat with emergency medicine. If you have multiple allergies or are on a complex medication regimen, it is important to have your pharmacist check for the presence of this dye in all your prescriptions to avoid an accidental reaction.
Fd&c Yellow No. 5 is not a drug itself, so the concept of 'generic' does not apply in the traditional sense. It is a standardized chemical additive. However, many generic medications use Fd&c Yellow No. 5 as a cheaper alternative to natural colorings. If you are trying to avoid this dye, you may need to look for specific 'dye-free' generic versions or certain brand-name medications that use different coloring agents. Pharmacists can use their database to identify which generic manufacturers include Fd&c Yellow No. 5 in their formulations. Often, the 'white' version of a tablet is the one that is free of this specific yellow dye.